(A) Differential gene expression analysis for TP53 at the uninfected baseline. (B)
TP53 expression in whole blood by qPCR before Pf infection. (C) Rotation self-contained gene set testing using a set of targets known to be activated by p53 for all comparisons at the uninfected baseline. Class differences in p53 expression determined by flow cytometry in peripheral CD14+ monocytes obtained at (D) the uninfected baseline (n=9) and (E) in May 2012 (n=26) using the anti-p53 monoclonal antibody clone PAb240. Triangles represent Pf-infected individuals. (F) Longitudinal p53 expression in CD14+ monocytes before, during acute malaria, and 7 days after treatment (n=11 subjects). (G) p53 expression in CD14+ monocytes in malaria-naïve US donors and malaria-exposed Malian donors using PAb240. (H) Change in % of IL-1β+ or TNF+ cells by intracellular staining after 12h stimulation of isolated CD14+ monocytes with Pf-infected red blood cell lysate (Pf lysate). Plasma concentrations of indicated cytokines in culture supernatants of (I) PBMCs (n=25 pairs); (J) CD14+ monocytes (n=6 pairs); and (K) CD14− non-monocytes (n=6 pairs) after 12 h stimulation with Pf lysate with and without the p53 stabilizer nutlin-3. (L) Changes in plasma concentrations of the indicated cytokines and (M) parasitemia in super p53 mice, which have an extra copy of Trp53, and wild-type littermates infected with Plasmodium yoelii 17XNL. Data are represented as mean ± standard error of the mean. Results are summarized data from five experiments that included 31 super-p53 mice and 33 wild-type mice. Significance differences between groups were determined by ANOVA with post-hoc Tukey’s HSD (B, E, F), Mann-Whitney (D, G, H), paired Wilcoxon tests (I, J, K), or t tests with Holm-Sidak-adjusted P values (L, M). ns = not significant, *P < 0.05.